Home › Kidney Diseases › North Carolina › Winston-Salem
Kidney Diseases clinical trials in Winston-Salem, NC
4 studies for Kidney Diseases are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
RecruitingPhase 3
- Brookview Hills Research Associates, LLC, Winston-Salem
Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Recruiting
- Wake Forest University Health Sciences, Winston-Salem
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RecruitingObservational study
- Atrium Health Wake Forest Baptist (Wake Forest Baptist), Winston-Salem
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RecruitingObservational studyHealthy volunteers welcome
- Wake Forest Health Sciences, Winston-Salem
About Kidney Diseases
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
More about Kidney Diseases on MedlinePlus
Kidney Diseases trials in other cities
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- New York City, NY5 studies
- Durham, NC5 studies
- Philadelphia, PA5 studies
- Dallas, TX5 studies
- Los Angeles, CA4 studies
- Cedar Rapids, IA4 studies
- Boston, MA4 studies
- Washington, DC4 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.